UPDATE: UBS Upgrades Seattle Genetics By: Benzinga via Benzinga July 09, 2014 at 11:44 AM EDT In a research note released Wednesday, UBS analyst Matthew Roden upgraded Seattle Genetics (NASDAQ: SGEN) from Neutral to Buy and ... Read More >> Related Stocks: Seagen Inc